These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 26851501)
1. Specific promoter deacetylation of histone H3 is conserved across mouse models of Huntington's disease in the absence of bulk changes. Guiretti D; Sempere A; Lopez-Atalaya JP; Ferrer-Montiel A; Barco A; Valor LM Neurobiol Dis; 2016 May; 89():190-201. PubMed ID: 26851501 [TBL] [Abstract][Full Text] [Related]
3. Histones associated with downregulated genes are hypo-acetylated in Huntington's disease models. Sadri-Vakili G; Bouzou B; Benn CL; Kim MO; Chawla P; Overland RP; Glajch KE; Xia E; Qiu Z; Hersch SM; Clark TW; Yohrling GJ; Cha JH Hum Mol Genet; 2007 Jun; 16(11):1293-306. PubMed ID: 17409194 [TBL] [Abstract][Full Text] [Related]
4. Genome-wide increase in histone H2A ubiquitylation in a mouse model of Huntington's disease. McFarland KN; Das S; Sun TT; Leyfer D; Kim MO; Xia E; Sangrey GR; Kuhn A; Luthi-Carter R; Clark TW; Sadri-Vakili G; Cha JH J Huntingtons Dis; 2013; 2(3):263-77. PubMed ID: 25062675 [TBL] [Abstract][Full Text] [Related]
5. Early alteration of epigenetic-related transcription in Huntington's disease mouse models. Hervás-Corpión I; Guiretti D; Alcaraz-Iborra M; Olivares R; Campos-Caro A; Barco Á; Valor LM Sci Rep; 2018 Jul; 8(1):9925. PubMed ID: 29967375 [TBL] [Abstract][Full Text] [Related]
6. Protection by dietary restriction in the YAC128 mouse model of Huntington's disease: Relation to genes regulating histone acetylation and HTT. Moreno CL; Ehrlich ME; Mobbs CV Neurobiol Dis; 2016 Jan; 85():25-34. PubMed ID: 26485309 [TBL] [Abstract][Full Text] [Related]
7. Treatment with JQ1, a BET bromodomain inhibitor, is selectively detrimental to R6/2 Huntington's disease mice. Kedaigle AJ; Reidling JC; Lim RG; Adam M; Wu J; Wassie B; Stocksdale JT; Casale MS; Fraenkel E; Thompson LM Hum Mol Genet; 2020 Jan; 29(2):202-215. PubMed ID: 31696228 [TBL] [Abstract][Full Text] [Related]
8. ESET/SETDB1 gene expression and histone H3 (K9) trimethylation in Huntington's disease. Ryu H; Lee J; Hagerty SW; Soh BY; McAlpin SE; Cormier KA; Smith KM; Ferrante RJ Proc Natl Acad Sci U S A; 2006 Dec; 103(50):19176-81. PubMed ID: 17142323 [TBL] [Abstract][Full Text] [Related]
9. Genome-wide histone acetylation is altered in a transgenic mouse model of Huntington's disease. McFarland KN; Das S; Sun TT; Leyfer D; Xia E; Sangrey GR; Kuhn A; Luthi-Carter R; Clark TW; Sadri-Vakili G; Cha JH PLoS One; 2012; 7(7):e41423. PubMed ID: 22848491 [TBL] [Abstract][Full Text] [Related]
10. Transcriptional and Histone Acetylation Changes Associated with CRE Elements Expose Key Factors Governing the Regulatory Circuit in the Early Stage of Huntington's Disease Models. Arancibia-Opazo S; Contreras-Riquelme JS; Sánchez M; Cisternas-Olmedo M; Vidal RL; Martin AJM; Sáez MA Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446028 [TBL] [Abstract][Full Text] [Related]
11. Epigenetics of Huntington's Disease. Bassi S; Tripathi T; Monziani A; Di Leva F; Biagioli M Adv Exp Med Biol; 2017; 978():277-299. PubMed ID: 28523552 [TBL] [Abstract][Full Text] [Related]
12. Mechanisms of disease: Histone modifications in Huntington's disease. Sadri-Vakili G; Cha JH Nat Clin Pract Neurol; 2006 Jun; 2(6):330-8. PubMed ID: 16932577 [TBL] [Abstract][Full Text] [Related]
13. Epigenetic modifications as novel therapeutic targets for Huntington's disease. Wang F; Fischhaber PL; Guo C; Tang TS Epigenomics; 2014 Jun; 6(3):287-97. PubMed ID: 25111483 [TBL] [Abstract][Full Text] [Related]
14. Neuronal identity genes regulated by super-enhancers are preferentially down-regulated in the striatum of Huntington's disease mice. Achour M; Le Gras S; Keime C; Parmentier F; Lejeune FX; Boutillier AL; Néri C; Davidson I; Merienne K Hum Mol Genet; 2015 Jun; 24(12):3481-96. PubMed ID: 25784504 [TBL] [Abstract][Full Text] [Related]
15. Epigenetic landscape of amphetamine and methamphetamine addiction in rodents. Godino A; Jayanthi S; Cadet JL Epigenetics; 2015; 10(7):574-80. PubMed ID: 26023847 [TBL] [Abstract][Full Text] [Related]
16. Epigenetic histone acetylation and deacetylation mechanisms in experimental models of neurodegenerative disorders. Konsoula Z; Barile FA J Pharmacol Toxicol Methods; 2012; 66(3):215-20. PubMed ID: 22902970 [TBL] [Abstract][Full Text] [Related]
17. Mitogen- and stress-activated protein kinase-1 deficiency is involved in expanded-huntingtin-induced transcriptional dysregulation and striatal death. Roze E; Betuing S; Deyts C; Marcon E; Brami-Cherrier K; Pagès C; Humbert S; Mérienne K; Caboche J FASEB J; 2008 Apr; 22(4):1083-93. PubMed ID: 18029446 [TBL] [Abstract][Full Text] [Related]
18. HDAC inhibition imparts beneficial transgenerational effects in Huntington's disease mice via altered DNA and histone methylation. Jia H; Morris CD; Williams RM; Loring JF; Thomas EA Proc Natl Acad Sci U S A; 2015 Jan; 112(1):E56-64. PubMed ID: 25535382 [TBL] [Abstract][Full Text] [Related]
19. Genomic landscape of transcriptional and epigenetic dysregulation in early onset polyglutamine disease. Valor LM; Guiretti D; Lopez-Atalaya JP; Barco A J Neurosci; 2013 Jun; 33(25):10471-82. PubMed ID: 23785159 [TBL] [Abstract][Full Text] [Related]